Showing results (191-200 of 4,510) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|March 25, 2006
Targeting the insulin-like growth factor axis as a cancer therapyTufia Haddad, Douglas Yee
Future Oncology (London, England)|March 25, 2006
Potential role of pulsed-high intensity focused ultrasound in gene therapyVictor Frenkel, King C P Li
Future Oncology (London, England)|November 29, 2007
Lung cancer susceptibility: are we on our way to identifying a high-risk group?Chikako Kiyohara, Kouichi Yoshimasu, Koichi Takayama, et al.
Future Oncology (London, England)|April 15, 2008
Capecitabine in the treatment of advanced gastric cancerJae-Lyun Lee, Yoon-Koo Kang
Future Oncology (London, England)|April 15, 2008
Front-line therapy for nonlocalized diffuse large B-cell lymphoma: what has been demonstrated and what is yet to be establishedErcole Brusamolino, Margherita Maffioli, Maurizio Bonfichi, et al.
Future Oncology (London, England)|April 15, 2008
miRNA modulation of the cellular stress responseImran A Babar, Frank J Slack, Joanne B Weidhaas
Future Oncology (London, England)|April 7, 2025
Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the USJason Hafron, Agnes Hong, Michael J Ryan, et al.
Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.
Future Oncology (London, England)|March 31, 2025
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
Future Oncology (London, England)|March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, et al.
Pageof 451